Company profile: Silicon Biosystems
1.1 - Company Overview
Company description
- Provider of lab-on-a-chip technologies for miniaturized cell-biology testing, including SmartSlide for enrichment and label-free separation, DEPArray for image-based cell sorting and single-cell isolation, CELLSEARCH tests for circulating tumor cells and multiple myeloma, CellMag products for immunomagnetic enrichment and staining, and Ampli1 kits for single-cell DNA analysis.
Products and services
- DEPArray: Microarray-based, image-guided technology that sorts and isolates cells, enabling molecular analyses with single-cell precision for miniaturized cell-biology testing and downstream characterization
- CELLSEARCH Circulating Tumor Cell Test: Assay-based test that detects circulating tumor cells in patients with metastatic breast, prostate, or colorectal cancer, supporting targeted evaluation of cancer-derived cells
- Ampli1 kits for single cell analysis: Kit-based portfolio engineered for single-cell DNA analysis, supporting study of individual-cell genomes within cell-biology testing workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Silicon Biosystems
Champions Oncology
HQ: United States
Website
- Description: Provider of advanced technology solutions and services for personalizing the development and use of oncology drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Champions Oncology company profile →
FEI
HQ: United States
Website
- Description: Provider of high-performance microscopy workflow solutions, designing, manufacturing, and supporting electron microscopes and FIB-SEM instruments for nanoscale imaging and sample preparation; Ion Torrent next-generation sequencing systems; monoclonal antibody development and support services; Thermo Scientific laboratory equipment; and custom and bulk lab chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FEI company profile →
Union Biometrica
HQ: United States
Website
- Description: Provider of high-throughput large-particle (10-1500 micron) flow cytometry systems for analyzing, sorting and dispensing objects too large or fragile for traditional cytometers. Products include COPAS FP, BioSorter and VISION for sorting by size, length, optical density and multiple fluorescence channels. Systems handle cells, cell clusters and small model organisms. VAST BioImager enables automated high-throughput, high-content screening and cellular-resolution imaging of zebrafish larvae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Union Biometrica company profile →
Inscripta
HQ: United States
Website
- Description: Provider of digital genome engineering solutions for life sciences.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inscripta company profile →
Protea Biosciences
HQ: United States
Website
- Description: Provider of mass spectrometry standards and services, including mass spectrometry imaging via LAESI and MALDI, HGMS integrating optical microscopy and histology, and LC-MS for proteomics, metabolomics, and protein characterization, enabling direct ionization, high-resolution spatial mapping, and targeted chemical profiling across diverse sample types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protea Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Silicon Biosystems
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Silicon Biosystems
2.2 - Growth funds investing in similar companies to Silicon Biosystems
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Silicon Biosystems
4.2 - Public trading comparable groups for Silicon Biosystems
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →